NCT07140562View on ClinicalTrials.gov

Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 15, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

December 31, 2026

Conditions

Tricuspid Regurgitation FunctionalTricuspid Regurgitation (TR)Tricuspid Regurgitation

Interventions

DEVICE

Tricuspid Annular Therapy System

A transcatheter device designed for tricuspid valve repair.

Trial Locations (1)

Unknown

RECRUITING

Sanatorio Italiano, Asunción

All Listed Sponsors

lead

Tangent Cardiovascular Inc.

INDUSTRY

NCT07140562 - Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation | Biotech Hunter | Biotech Hunter